It was reported that SCFAs could activate G-protein coupled receptors and downstream NF-κB against virus infection, such as GPR41, GPR43, and GPR109a (Feng et al., 2018; Trompette et al., 2018; Antunes et al., 2019). This evidence concerns the gene FFAR2 and viral infectious disease.